Michal Shavit

Statistics

Publications

Citations

202

H-Index

Active since

2012

Affiliations

Technion – Israel Institute of Technology(Current)

Michal Shavit is an author at Technion – Israel Institute of Technology specializing in life sciences, ribosome biogenesis, and antibiotic resistance.

Publications per year

2012–2018

Publications

Increased Selectivity toward Cytoplasmic versus Mitochondrial Ribosome Confers Improved Efficiency of Synthetic Aminoglycosides in Fixing Damaged Genes: A Strategy for Treatment of Genetic Diseases Caused by Nonsense Mutations

Jeyakumar Kandasamy, Dana Atia-Glikin, Eli Shulman et al. · Journal of Medicinal Chemistry · 2012 · 74 citations

Life Sciences, Genetics, Molecular Biology +11

Covalently linked kanamycin – Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance

Michal Shavit, Varvara Pokrovskaya, Valery Belakhov et al. · Bioorganic & Medicinal Chemistry · 2017 · 54 citations

Life Sciences, Microbiology, Pharmacology +14

Design of Novel Aminoglycoside Derivatives with Enhanced Suppression of Diseases-Causing Nonsense Mutations

Narayana Murthy Sabbavarapu, Michal Shavit, Yarden Degani et al. · ACS Medicinal Chemistry Letters · 2016 · 37 citations · Full text

Pharmacy, Genetics, Molecular Biology +17

A Hybrid Drug Limits Resistance by Evading the Action of the Multiple Antibiotic Resistance Pathway

Kathy K. Wang, Laura K. Stone, Tami D. Lieberman et al. · Molecular Biology and Evolution · 2015 · 27 citations · Full text

Life Sciences, Evolutionary Biology, Microbiology +17

Towards Catalytic Antibiotics: Redesign of Aminoglycosides To Catalytically Disable Bacterial Ribosomes

Boris Smolkin, Alina Khononov, Tomasz Pieńko et al. · ChemBioChem · 2018 · 10 citations

Pharmacy, Medicinal Chemistry, Molecular Biology +17

1–5 of 5